Biotech

Biggest Stock Gainers Today: Biotech Breakouts and IBM–Confluent Deal Lead U.S. Market Movers (December 8, 2025)

U.S. stocks traded mostly flat on Monday as Wall Street headed into a crucial Federal Reserve meeting, but under the surface the tape was anything but quiet. While the S&P 500 and Dow Jones Industrial Average hovered around unchanged and

8 December 2025

Top Pre‑Market Gainers Today (December 8, 2025): Confluent, Carvana and Biotech Names Lead Fed‑Week Rally

U.S. stock futures are edging higher on Monday, December 8, 2025, as traders head into a pivotal Federal Reserve meeting widely expected to deliver this year’s final rate cut. Nasdaq 100 futures are up around a quarter of a percent,

8 December 2025

Biotech Stocks · Financial News · Investing · NASDAQ:ACLX · NASDAQ:AVGO · NASDAQ:CFLT · NASDAQ:DYN · NASDAQ:FULC · NASDAQ:HOOD · NASDAQ:KYMR · NASDAQ:MU · NASDAQ:OCUL · NASDAQ:RGNX · NASDAQ:TER · NYSE:ALB · NYSE:CVNA · NYSE:IBM · Pre-Market Movers · Stock Market

NVAX Stock Today: Can Novavax Turn Regulatory Turmoil and Activist Pressure into a Comeback?

Data and news current as of 7 December 2025. NVAX stock price now: where Novavax stands in December 2025 Novavax, Inc. (NASDAQ: NVAX) closed on Friday, 5 December 2025 at $6.91 per share, giving the vaccine maker a market value

7 December 2025

Biotech · Investing · Market Analysis · NASDAQ:NVAX · Pharma Industry · Stocks

Moderna (MRNA) Stock Jumps on Vaccine Safety Study and $1.5B Lifeline: Latest News and Forecasts as of December 6, 2025

Moderna Inc. (NASDAQ: MRNA) is back in the spotlight. After months of pressure from collapsing COVID‑19 vaccine demand and rising regulatory scrutiny, the stock has staged a sharp rebound in early December 2025 — powered by a major long‑term safety

6 December 2025

Biotechnology · Financial Forecasts · Market News · NASDAQ:MRNA · Stocks · Vaccines

Moderna (MRNA) Stock: French Study Sparks Rally After FDA Shock – Latest News, Analyst Forecasts and 2026 Outlook

Updated: December 6, 2025 Moderna, Inc. (NASDAQ: MRNA) has just had one of its most dramatic weeks of 2025. Shares plunged early in the week after news that the U.S. Food and Drug Administration (FDA) may tighten vaccine approval standards,

6 December 2025

Analysis · Biotech · Forecasts · Market News · NASDAQ:MRNA · Stocks

Aditxt (ADTX) Stock on December 5, 2025: BitXbio Pivot, Reverse Split and Survival Risk Explained

Published: December 5, 2025 Key Takeaways This article summarizes the latest news, forecasts, and analyses on Aditxt, Inc. (NASDAQ: ADTX) as of December 5, 2025, based on regulatory filings, company press releases and market data. It is informational only and

5 December 2025

Biotechnology · Company Analysis · Financial News · Investment Insights · NASDAQ:ADTX · Stock Market

IonQ Stock (IONQ) on December 5, 2025: Quantum Breakthroughs, Biotech Deals, Big Money Flows and 2026 Forecast

IonQ, Inc. (NYSE: IONQ) is back in the spotlight today after another burst of volatility that has pushed the stock to around the low‑$50s per share as of December 5, 2025. Different data sources show IONQ trading in the $51–55

5 December 2025

NYSE:IONQ

Praxis Precision Medicines (PRAX) Soars on FDA Momentum and Epilepsy Breakthroughs as Stock Hits New High on December 5, 2025

Praxis Precision Medicines, Inc. (NASDAQ: PRAX) extended its remarkable 2025 rally on Friday, December 5, with shares surging almost 40% intraday after the company reported a double dose of good news: a pivotal epilepsy trial stopped early for efficacy and

5 December 2025

Biotech Stocks · Epilepsy Research · FDA Approvals · Investment News · NASDAQ:PRAX · Pharmaceutical Industry

Sensei Biotherapeutics (SNSE) Stock: Wild Volatility After Solnerstotug Shutdown and Strategic Review – Price, News and 2025–2026 Forecast

Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) has suddenly landed back on traders’ radars. After months of drifting as a tiny, cash‑rich micro‑cap biotech, the stock exploded higher at the start of December 2025 – just weeks after the company killed its

5 December 2025

Biotech Stocks · Financial Forecasts · Investment News · Market Analysis · NASDAQ:SNSE · Stock Market

IonQ Stock Jumps After Quantum Breakthroughs and Biotech Deal: IONQ Price, Forecast and Outlook as of December 5, 2025

IonQ, Inc. (NYSE: IONQ) is once again at the center of the quantum-computing spotlight. After a sharp pullback in November, the quantum hardware specialist has ripped higher into early December on the back of record-breaking technical milestones, a new biotech

5 December 2025

Biotech News · Financial Forecast · Investment Analysis · NYSE:IONQ · Quantum Computing · Stock Market

Polyrizon (PLRZ) Stock Explodes on Naloxone Hydrogel Breakthrough and PL‑14 Upscaling – What Investors Should Know Now

Polyrizon Ltd. (NASDAQ: PLRZ) has gone from obscure micro‑cap to headline‑grabbing biotech in just two trading days. On December 4, 2025, the stock was changing hands in the mid‑teens, more than doubling from the prior close of $7.09, with intraday

4 December 2025

Biotechnology · Healthcare Innovation · Investment Tips · NASDAQ:PLRZ · Pharma News · Stock Market

Hims & Hers (HIMS) Stock Jumps on Canada Launch and YourBio Deal: Latest News, Forecasts and Analysis for December 4, 2025

Hims & Hers Health, Inc. (NYSE: HIMS) is back in the spotlight. In Thursday’s session on December 4, 2025, the telehealth stock climbed roughly 5–8%, trading around $40 and valuing the company at about $12.8 billion, after a flurry of

4 December 2025

Company News · Financial Forecasts · Health Tech · Investment Analysis · NYSE:HIMS · Stock Market